Ischemic Optic Neuropathies

  • Jane W. Chan


Nonarteritic anterior ischemic optic neuropathy (NAION) is a relatively common disorder. The yearly incidence of NAION is 2.3 to 10.2 per 100,000 persons over 50 years of age and 0.5 per 100,000 for all ages.1 Although NAION usually affects patients older than 50 years, 2,3 it may also occasionally occur in younger patients. In a study by Hayreh et al.3 of 406 patients with NAION, the mean age of affected patients was 60 ± 14 years, with a range of 11 to 91 years. Eleven percent of the study patients were younger than 45 years, 49% were between 45 and 64 years, and 40% were 65 years or older. There is no sex predilection.3-5 Caucasians have a smaller cup-to-disc ratio compared to that of African Americans. Most patients affected with NAION are, therefore, Caucasians.6


Optic Disc Giant Cell Arteritis Optic Nerve Head Temporal Arteritis Temporal Artery Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuro-Ophthalmol 1994;14(1):38–44.Google Scholar
  2. 2.
    Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic Anterior ischemic optic neuropathy. Am J Ophthalmol 1994;118(6):766–780.PubMedGoogle Scholar
  3. 3.
    Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and history. Brain 1975;98(4):689–708.PubMedGoogle Scholar
  4. 4.
    Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996;114(11):1366–1374.Google Scholar
  5. 5.
    Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985;103(8):1136–1142.PubMedGoogle Scholar
  6. 6.
    Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol 2005; 123(11):1554–1562.PubMedGoogle Scholar
  7. 7.
    Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983;96(4):478–483.PubMedGoogle Scholar
  8. 8.
    Spalton DJ, Hitchings RA, Hunter PA, editors; Tan JCH, associate editor; Harry J, pathology advisor. Atlas of clinical ophthalmology. Philadelphia, Edinburgh: Elsevier Mosby; 2005.Google Scholar
  9. 9.
    Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthalmol 2003;23(2):157–163.Google Scholar
  10. 10.
    Danesh-Meyer HV, Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2001;108(3):593–598.PubMedGoogle Scholar
  11. 11.
    Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 1995;273(8):625–632.Google Scholar
  12. 12.
    Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. Arch Ophthalmol 2000;118(6):793–798.Google Scholar
  13. 13.
    Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthalmol 1994;14(2):66–69.Google Scholar
  14. 14.
    Hayreh SS. Anterior ischaemic optic neuropathy. Differentiation of arteritic from nonarteritic type and its management. Eye 1990;4(pt 1):25–41.PubMedGoogle Scholar
  15. 15.
    Newman NJ, Scherer R, Langenberg P, et al.; Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134(3):317–328.PubMedGoogle Scholar
  16. 16.
    Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123(2):212–217.PubMedGoogle Scholar
  17. 17.
    Goff MJ, Kerrison JB. Bilateral simultaneous anterior ischemic optic neuropathy in a young, healthy man. Arch Ophthalmol 2003;121(11):1652–1653.PubMedGoogle Scholar
  18. 18.
    Lee AG, Lin DJ, Kaufman M, Golnik KC, Vaphiades MS, Eggenberger E. Atypical features prompting neuroimaging in acute optic neuropathy in adults. Can J Ophthalmol 2000;35(6):325–330.PubMedGoogle Scholar
  19. 19.
    Miller NR, Newman NJ, editors. Walsh and Hoyt’ s clinical neuro-ophthalmology, 5th ed. Baltimore: Williams & Wilkins; 1998.Google Scholar
  20. 20.
    Rath EZ, Rehany U, Linn S, Rumelt S. Correlation between optic disc atrophy and aetiology: anterior ischaemic optic neuropathy vs. optic neuritis. Eye 2003;17(9):1019–1024.PubMedGoogle Scholar
  21. 21.
    Arnold AC. Anterior ischemic optic neuropathy following ocular pneumoplethysmography. J Clin Neuro-Ophthalmol 1987;7(1):58–59.Google Scholar
  22. 22.
    Rizzo JF III, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109(9):1679–1684.PubMedGoogle Scholar
  23. 23.
    Chung SM, Gay CA, McCrary JA III. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994;101(4):779–782.PubMedGoogle Scholar
  24. 24.
    Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol 1997;115(11):1403–1407.PubMedGoogle Scholar
  25. 25.
    Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999;106(4):739–742.PubMedGoogle Scholar
  26. 26.
    Fry CL, Carter JE, Kanter MC, Tegeler CH, Tuley MR. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993;24(4):539–542.PubMedGoogle Scholar
  27. 27.
    Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2003;110(10):2031–2035.PubMedGoogle Scholar
  28. 28.
    Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984;91(11):1334–1337.PubMedGoogle Scholar
  29. 29.
    Feit RH, Tomsak RL, Ellenberger C Jr. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol 1984;98(1):105–108.PubMedGoogle Scholar
  30. 30.
    Eagling EM, Sanders MD, Miller SJ. Ischaemic papillopathy. Clinical and fluorescein angiographic review of forty cases. Br J Ophthalmol 1974;58(12):990–1008.PubMedGoogle Scholar
  31. 31.
    Arnold AC, Badr MA, Hepler RS. Fluorescein angiography in nonischemic optic disc edema. Arch Ophthalmol 1996;114(3):293–298.PubMedGoogle Scholar
  32. 32.
    Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;117(2):222–230.PubMedGoogle Scholar
  33. 33.
    Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000;98:203–220; discussion 221–2.PubMedGoogle Scholar
  34. 34.
    Olver JM, Spalton DJ, McCartney AC. Microvascular study of the retrolaminar optic nerve in man: the possible significance in anterior ischaemic optic neuropathy. Eye 1990;4(pt 1):7–24.PubMedGoogle Scholar
  35. 35.
    Onda E, Cioffi GA, Bacon DR, Van Buskirk EM. Microvasculature of the human optic nerve. Am J Ophthalmol 1995;120(1):92–102.PubMedGoogle Scholar
  36. 36.
    Hayreh SS, Piegors DJ, Heistad DD. Serotonininduced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of the retina and optic nerve head. Arch Ophthalmol 1997;115(2):220–228.PubMedGoogle Scholar
  37. 37.
    Landau K, Winterkorn JM, Mailloux LU, Vetter W, Napolitano B. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996;114(5):570–575.PubMedGoogle Scholar
  38. 38.
    Harris A, Ciulla TA, Chung HS, Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol 1998;116(11):1491–1495.PubMedGoogle Scholar
  39. 39.
    Hayreh SS. Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Prog Ret Eye Res 1999;18(2):191–221.Google Scholar
  40. 40.
    Strenn K, Matulla B, Wolzt M, et al. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther 1998;63(1):54–63.PubMedGoogle Scholar
  41. 41.
    Oku H, Sugiyama T, Kojima S, Watanabe T, Azuma I. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol 1999;44(suppl 1):S74–84.PubMedGoogle Scholar
  42. 42.
    Saraux H, Murat JP. Pseudopapillitis of vascular origin. Ann Ocul (Paris) 1967;200(1):1–19.Google Scholar
  43. 43.
    Keltner JL, Becker B, Gay AJ, Podos SM. Effect of diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc 1972;70:113–130.PubMedGoogle Scholar
  44. 44.
    Johnson LN, Gould TJ, Krohel GB. Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months’ duration. Am J Ophthalmol 1996;121(1):77–83.PubMedGoogle Scholar
  45. 45.
    Smith JL. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuro-Ophthalmol 1981;1(4):289–290.Google Scholar
  46. 46.
    Kollarits CR, McCarthy RW, Corrie WS, et al. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuro-Ophthalmol 1981;1:283–288.Google Scholar
  47. 47.
    Kajiwara K, Tsubota K, Hara Y. High-dose urokinase thrombolysis and stellate ganglion block for anterior ischemic optic neuropathy. Folia Ophthalmol Jpn 1990;41:59–64.Google Scholar
  48. 48.
    Hayreh SS. AION. Berlin: Springer-Verlag; 1975.Google Scholar
  49. 49.
    Botelho PJ, Johnson LN, Arnold AC. The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1996;121(4):450–451.PubMedGoogle Scholar
  50. 50.
    Maas A, Walzl M, Jesenik F, et al. Application of HELP in nonarteritic anterior ischemic optic neuropathy: a prospective, randomized, controlled study. Graefe’ s Arch Clin Exp Ophthalmol 1997;235:14–19.Google Scholar
  51. 51.
    Yee RD, Selky AK, Purvin VA. Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J NeuroOphthalmol 1994;14(2):70–76.PubMedGoogle Scholar
  52. 52.
    Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. J Ophthalmol 1997;123(2):212–217.Google Scholar
  53. 53.
    Newman NJ, Scherer R, Langenberg P, et al.; Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134(3):317–328.PubMedGoogle Scholar
  54. 54.
    The BRAION study group; Wilhelm B, Ludtke H, Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, ran-domized, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 2006;244(5):551–558.PubMedGoogle Scholar
  55. 55.
    Johnson LN, Guy ME, Krohel GB, Madsen RW. Levodopa may improve vision loss in recentonset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2000;107(3):521–526.PubMedGoogle Scholar
  56. 56.
    Simsek T, Eryilmaz T, Acaroglu G. Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy. Int J Clin Pract 2005;59(3):287–290.PubMedGoogle Scholar
  57. 57.
    Bojic L, Ivanisevic M, Gosovic G. Hyperbaric oxygen therapy in two patients with nonarteritic anterior optic neuropathy who did not respond to prednisone. Undersea Hyper Med 2002;29(2):86–92.Google Scholar
  58. 58.
    Bojic L, Cerovski B, Bucan K, et al. Hyperbaric oxygen for the treatment of nonarteritic anterior ischemic optic neuropathy. Acta Med Croat 1995;49(3):133–136.Google Scholar
  59. 59.
    Bojic L, Kovacevic H, Andric D, KaramanKraljevic K, Cagalj S. The effects of hyperbaric oxygen on visual functions in ischaemic optic neuropathy. Arh Hig Rad Toksikol 1994;45(1):19–24.Google Scholar
  60. 60.
    Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1996;122(4):535–541.PubMedGoogle Scholar
  61. 61.
    Soheilian M, Koochek A, Yazdani S, Peyman GA. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina 2003;23(5):692–697.PubMedGoogle Scholar
  62. 62.
    Lubow M, Makley TA Jr. Pseudopapilledema of juvenile diabetes mellitus. Arch Ophthalmol 1971;85(4):417–422.PubMedGoogle Scholar
  63. 63.
    Barr CC, Glaser JS, Blankenship G. Acute disc swelling in juvenile diabetes. Clinical profile and natural history of 12 cases. Arch Ophthalmol 1980;98(12):2185–2192.PubMedGoogle Scholar
  64. 64.
    Pavan PR, Aiello LM, Wafai MZ, Briones JC, Sebestyen JG, Bradbury MJ. Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol 1980;98(12):2193–2195.PubMedGoogle Scholar
  65. 65.
    Hayreh SS, Zahoruk RM. Anterior ischemic optic neuropathy. VI. In juvenile diabetics. Ophthalmologica 1981;182(1):13–28.PubMedGoogle Scholar
  66. 66.
    Friedland S, Winterkorn JM, Burde RM. Luxury perfusion following anterior ischemic optic neuropathy. J Neuro-Ophthalmol 1996;16(3):163–171.Google Scholar
  67. 67.
    Ho AC, Maguire AM, Yanuzzi LA, et al. Rapidly progressive optic disc neovascularization after diabetic papillopathy. Am J Ophthalmol 1995;120:673–675.PubMedGoogle Scholar
  68. 68.
    Katz B. Disc swelling in an adult diabetic patient. Surv Ophthalmol 1990;35(2):158–163.PubMedGoogle Scholar
  69. 69.
    Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol 1995;113(7):889–895.PubMedGoogle Scholar
  70. 70.
    Sato T, Fujikado T, Hosohata J, Ohji M, Tano Y. Development of bilateral, nonarteritic anterior ischemic optic neuropathy in an eye with diabetic papillopathy. Jpn J Ophthalmol 2004;48(2):158–162.PubMedGoogle Scholar
  71. 71.
    Munteanu M, Lehaci C. Acute anterior ischemic optic neuropathy in association with optic nerve drusen. Oftalmologia 2004;48(3):16–19.PubMedGoogle Scholar
  72. 72.
    Purvin V, King R, Kawasaki A, Yee R. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch Ophthalmol 2004;122(1):48–53.PubMedGoogle Scholar
  73. 73.
    Weger M, Haas A, Stanger O, et al. Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy. Ophthalmology 2002;109(4):749–752.PubMedGoogle Scholar
  74. 74.
    Vecsei PV, Kircher K, Reitner A, Khanakha G, Stanek G. Chlamydia in anterior ischemic optic neuropathy. Ophthalmologica 2002;216(3):215–220.PubMedGoogle Scholar
  75. 75.
    Drance SM, Morgan RW, Sweeney VP. Shock-induced optic neuropathy: a cause of nonprogressive glaucoma. N Engl J Med 1973;288(8):392–395.PubMedGoogle Scholar
  76. 76.
    Hayreh SS. Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology 1987;94(11):1488–1502.PubMedGoogle Scholar
  77. 77.
    Hollenhorst RW, Wagener HP. Loss of vision after distant hemorrhage. Am J Med Sci 1950;219:209–244.PubMedGoogle Scholar
  78. 78.
    Moster ML. Visual loss after coronary artery bypass surgery. Surv Ophthalmol 1998;42(5):453–457.PubMedGoogle Scholar
  79. 79.
    Foroozan R, Buono LM, Savino PJ. Optic disc structure and shock-induced anterior ischemic optic neuropathy. Ophthalmology 2003;110(2):327–331.PubMedGoogle Scholar
  80. 80.
    Chisholm IA. Optic neuropathy of recurrent blood loss. Br J Ophthalmol 1969;53(5):289–295.PubMedGoogle Scholar
  81. 81.
    Lazaro EJ, Cinotti AA, Eichler PN, Khawaja AA. Amaurosis due to massive gastrointestinal hemorrhage. Am J Gastroenterol 1971;55(1):50–53.PubMedGoogle Scholar
  82. 82.
    Klewin KM, Appen RE, Kaufman PL. Amaurosis and blood loss. Am J Ophthalmol 1978;86(5):669–672.PubMedGoogle Scholar
  83. 83.
    Johnson MW, Kincaid MC, Trobe JD. Bilateral retrobulbar optic nerve infarctions after blood loss and hypotension. A clinicopathologic case study. Ophthalmology 1987;94(12):1577–1584.PubMedGoogle Scholar
  84. 84.
    Chan JW. Acute bilateral simultaneous PION after ectopic pregnancy-related haemorrhage. Eye 2006;20(6):747–748.PubMedGoogle Scholar
  85. 85.
    Presencia AC, Hernandez, Guia ED. Amaurosis following blood loss. Ophthalmologica 1985;191:119–122.Google Scholar
  86. 86.
    Basile C, Addabbo G, Montanaro A. Anterior ischemic optic neuropathy and dialysis: role of hypotension and anemia. J Nephrol 2001;14(5):420–423.PubMedGoogle Scholar
  87. 87.
    Chutorian AM, Winterkorn JM, Geffner M. Anterior ischemic optic neuropathy in children: case reports and review of the literature. Pediatr Neurol 2002;26(5):358–364.PubMedGoogle Scholar
  88. 88.
    Servilla KS, Groggel GC. Anterior ischemic optic neuropathy as a complication of hemodialysis. Am J Kidney Dis 1986;8(1):61–63.PubMedGoogle Scholar
  89. 89.
    Hamed LM, Winward KE, Glaser JS, Schatz NJ. Optic neuropathy in uremia. Am J Ophthalmol 1989;108(1):30–35.PubMedGoogle Scholar
  90. 90.
    Connolly SE, Gordon KB, Horton JC. Salvage of vision after hypotension-induced ischemic optic neuropathy. Am J Ophthalmol 1994;117(2):235–242.PubMedGoogle Scholar
  91. 91.
    Korzets A, Marashek I, Schwartz A, Rosenblatt I, Herman M, Ori Y. Ischemic optic neuropathy in dialyzed patients: a previously unrecognized manifestation of calcific uremic arteriolopathy. Am J Kidney Dis 2004;44(6):e93–e97.PubMedGoogle Scholar
  92. 92.
    Alpert JN, Pena Y, Leachman DR. Anterior ischemic optic neuropathy after coronary bypass surgery. Tex Med 1987;83(8):45–47.PubMedGoogle Scholar
  93. 93.
    Larkin DF, Wood AE, Neligan M, Eustace P. Ischaemic optic neuropathy complicating cardiopulmonary bypass. Br J Ophthalmol 1987;71(5):344–347.PubMedGoogle Scholar
  94. 94.
    Rizzo JF III, Lessell S. Posterior ischemic optic neuropathy during general surgery. Am J Ophthalmol 1987;103(6):808–811.PubMedGoogle Scholar
  95. 95.
    Shahian DM, Speert PK. Symptomatic visual deficits after open heart operations. Ann Thorac Surg 1989;48(2):275–279.PubMedGoogle Scholar
  96. 96.
    Tice DA. Ischemic optic neuropathy and cardiac surgery. Ann Thorac Surg 1987;44(6):677.PubMedGoogle Scholar
  97. 97.
    Brown RH, Schauble JF, Miller NR. Anemia and hypotension as contributors to perioperative loss of vision. Anesthesiology 1994;80(1):222–226.PubMedGoogle Scholar
  98. 98.
    Ballen PH, Fox MJ, Weissman GS. Ischemic optic neuropathy secondary to intestinal hemorrhage. Ann Ophthalmol 1985;17(8):486–488.PubMedGoogle Scholar
  99. 99.
    Jaben SL, Glaser JS, Daily M. Ischemic optic neuropathy following general surgical procedures. J Clin Neuro-Ophthalmol 1983;3(4):239–244.Google Scholar
  100. 100.
    Katz DM, Trobe JD, Cornblath WT, Kline LB. Ischemic optic neuropathy after lumbar spine surgery. Arch Ophthalmol 1994;112(7):925–931.PubMedGoogle Scholar
  101. 101.
    Lee AG. Ischemic optic neuropathy following lumbar spine surgery. Case report. J Neurosurg 1995;83(2):348–349.PubMedGoogle Scholar
  102. 102.
    Tidow-Kebritchi S, Jay WM. Anterior ischemic optic neuropathy following off-pump cardiac bypass surgery. Semin Ophthalmol 2003;18(4):166–168.PubMedGoogle Scholar
  103. 103.
    Foroozan R, Varon J. Bilateral anterior ischemic optic neuropathy after liposuction. J Neuro-Ophthalmol 2004;24(3):211–213.Google Scholar
  104. 104.
    Minagar A, Schatz NJ, Glaser JS. Liposuction and ischemic optic neuropathy. Case report and review of literature. J Neurol Sci 2000;181(1–2):132–136.PubMedGoogle Scholar
  105. 105.
    Tomsak RL, Remler BF. Anterior ischemic optic neuropathy and increased intraocular pressure. J Clin Neuro-Ophthalmol 1989;9(2):116–118.Google Scholar
  106. 106.
    Katz B. Anterior ischemic optic neuropathy and intraocular pressure. Arch Ophthalmol 1992;110(5):596–597.PubMedGoogle Scholar
  107. 107.
    Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117(5):603–624.PubMedGoogle Scholar
  108. 108.
    Chung SM, Gay CA, McCrary JA III. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994;101(4):779–782.PubMedGoogle Scholar
  109. 109.
    Shiose Y. Intraocular pressure: new perspectives. Surv Ophthalmol 1990;34(6):413–435.PubMedGoogle Scholar
  110. 110.
    Williams EL, Hart WM Jr, Tempelhoff R. Postoperative ischemic optic neuropathy. Anesth Analg 1995;80(5):1018–1029.PubMedGoogle Scholar
  111. 111.
    Abraham M, Sakhuja N, Sinha S, Rastogi S. Unilateral visual loss after cervical spine surgery. J Neurosurg Anesthesiol 2003;15(4):319–322.PubMedGoogle Scholar
  112. 112.
    Golnik KC, Newman SA. Anterior ischemic optic neuropathy associated with macrocytic anemia. J Clin Neuro-Ophthalmol 1990;10(4):244–247.Google Scholar
  113. 113.
    Foulds WS, Chisholm IA, Stewart JB, Wilson TM. The optic neuropathy of pernicious anemia. Arch Ophthalmol 1969;82(4):427–432.PubMedGoogle Scholar
  114. 114.
    Kacer B, Hattenbach LO, Horle S, Scharrer I, Kroll P, Koch F. Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia. Ophthalmologica 2001;215(2):128–131.PubMedGoogle Scholar
  115. 115.
    Acheson JF, Sanders MD. Coagulation abnormalities in ischaemic optic neuropathy. Eye 1994;8(pt 1):89–92.PubMedGoogle Scholar
  116. 116.
    Nagy V, Facsko A, Takacs L, et al. Activated protein C resistance in anterior ischaemic optic neuropathy. Acta Ophthalmol Scand 2004;82(2):140–143.PubMedGoogle Scholar
  117. 117.
    Stanger O, Weger M, Obeid R, et al. Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy. Clin Chem Lab Med 2005;43(10):1020–1025.PubMedGoogle Scholar
  118. 118.
    Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with nonarteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1999;83(11):1287–1290.PubMedGoogle Scholar
  119. 119.
    Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation. J Lab Clin Med 2004;143(3):184–192.PubMedGoogle Scholar
  120. 120.
    Weger M, Stanger O, Deutschmann H, et al. Hyperhomocysteinaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol 2001;85(7):803–806.PubMedGoogle Scholar
  121. 121.
    Salomon O, Rosenberg N, Steinberg DM, et al. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ib alpha gene. Ophthalmology 2004;111(1):184–188.PubMedGoogle Scholar
  122. 122.
    Levine SR. Hypercoagulable states and stroke: a selective review. CNS Spectr 2005;10(7):567–578.PubMedGoogle Scholar
  123. 123.
    Luescher TF. The endothelium and cardiovascular disease: a complex relationship. N Engl J Med 1994;330:1081–1083.Google Scholar
  124. 124.
    Corbett JJ. Neuro-ophthalmic complications of migraine and cluster headaches. Neurol Clin 1983;1(4):973–995.PubMedGoogle Scholar
  125. 125.
    Cowan CL Jr, Knox DL. Migraine optic neuropathy. Ann Ophthalmol 1982;14(2):164–166.PubMedGoogle Scholar
  126. 126.
    Katz B, Bamford CR. Migrainous ischemic optic neuropathy. Neurology 1985;35(1):112–114.PubMedGoogle Scholar
  127. 127.
    McDonald WI, Sanders MD. Migraine complicated by ischaemic papillopathy. Lancet 1971;2(7723):521–523.PubMedGoogle Scholar
  128. 128.
    Victor DI, Welch RB. Bilateral retinal hemorrhages and disk edema in migraine. Am J Ophthalmol 1977;84(4):555–558.PubMedGoogle Scholar
  129. 129.
    Weinstein JM, Feman SS. Ischemic optic neuropathy in migraine. Arch Ophthalmol 1982;100(7):1097–1100.PubMedGoogle Scholar
  130. 130.
    Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Ret Eye Res 2001;20(3):319–349.Google Scholar
  131. 131.
    Rufa A, De Stefano N, Dotti MT, et al. Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arch Neurol 2004;61(4):577–580.PubMedGoogle Scholar
  132. 132.
    Mojon DS, Hedges TR III, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemicoptic neuropathy. Arch Ophthalmol 2002;120(5):601–605.PubMedGoogle Scholar
  133. 133.
    Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997;124(5):641–647.PubMedGoogle Scholar
  134. 134.
    Hayreh SS. The 1994 Von Sallman Lecture. The optic nerve head circulation in health and disease. Exp Eye Res 1995;61(3):259–272.PubMedGoogle Scholar
  135. 135.
    Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000;118(12):1626–1630.PubMedGoogle Scholar
  136. 136.
    Behbehani R, Mathews MK, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol 2005;139(3):518–521.PubMedGoogle Scholar
  137. 137.
    Keltner JL. Giant-cell arteritis. Signs and symptoms. Ophthalmology 1982;89(10):1101–1110.PubMedGoogle Scholar
  138. 138.
    Aiello AL, Sadun AA, Feldon SE. Spontaneous improvement of progressive anterior ischemic optic neuropathy: report of two cases. Arch Ophthalmol 1992;110(9):1197–1199.PubMedGoogle Scholar
  139. 139.
    Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101(11):1779–1785.PubMedGoogle Scholar
  140. 140.
    Liu NH, LaBree LD, Feldon SE, Rao NA. The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology 2001;108(6):1145–1149.PubMedGoogle Scholar
  141. 141.
    Tomsak RL. Giant cell arteritis. Ophthalmology 2002;109(2):219–220.PubMedGoogle Scholar
  142. 142.
    Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347(4):261–271.PubMedGoogle Scholar
  143. 143.
    Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123(3):285–296.PubMedGoogle Scholar
  144. 144.
    Gonzalez-Gay MA, Garcia-Porrua C, MirandaFilloy JA. Giant cell arteritis: diagnosis and therapeutic management. Curr Rheumatol Rep 2006;8(4):299–302.PubMedGoogle Scholar
  145. 145.
    Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998;125(4):521–526.PubMedGoogle Scholar
  146. 146.
    Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology 2001;108(9):1586–1594.PubMedGoogle Scholar
  147. 147.
    Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM. Formation of new vaso vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999;155(3):765–774.PubMedGoogle Scholar
  148. 148.
    Wagner AD, Bjornsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol 1996;148(6):1925–1933.PubMedGoogle Scholar
  149. 149.
    Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997;3(8):530–543.PubMedGoogle Scholar
  150. 150.
    Martinez-Taboada V, Hunder NN, Hunder GG, Weyand CM, Goronzy JJ. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med 1996;74(11):695–703.PubMedGoogle Scholar
  151. 151.
    Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoidmediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997;99(12):2842–2850.PubMedGoogle Scholar
  152. 152.
    Rittner HL, Kaiser M, Brack A, Szweda LI, Goronzy JJ, Weyand CM. Tissue-destructive macrophages in giant cell arteritis. Circ Res 1999;84(9):1050–1058.PubMedGoogle Scholar
  153. 153.
    Weyand CM, Goronzy JJ. Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med. 2002;69(suppl 2):SII28–32.PubMedGoogle Scholar
  154. 154.
    Mitchell BM, Font RL. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest Ophthalmol Vis Sci 2001;42(11):2572–2577.PubMedGoogle Scholar
  155. 155.
    Rimenti G, Blasi F, Cosentini R, et al. Temporal arteritis associated with Chlamydiapneumoniae DNA detected in an artery specimen. J Rheumatol 2000;27(11):2718–2720.PubMedGoogle Scholar
  156. 156.
    Haugeberg G, Bie R, Nordbo SA. Temporal arteritis associated with Chlamydiapneumoniae DNA detected in an artery specimen. J Rheumatol. 2001;28(7):1738–1739.PubMedGoogle Scholar
  157. 157.
    Regan MJ, Wood BJ, Hsieh YH, et al. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum 2002;46(4):1056–1060.PubMedGoogle Scholar
  158. 158.
    Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxf) 2002;41(4):445–449.Google Scholar
  159. 159.
    Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33(8):1122–1128.PubMedGoogle Scholar
  160. 160.
    Evans JM, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin N Am 2000;26(3):493–515.Google Scholar
  161. 161.
    Jundt JW, Mock D. Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 1991;34(2):217–219.PubMedGoogle Scholar
  162. 162.
    Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001;45(2):140–145.PubMedGoogle Scholar
  163. 163.
    Wise CM, Agudelo CA, Chmelewski WL, McKnight KM. Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 1991;34(12):1571–1574.PubMedGoogle Scholar
  164. 164.
    Wong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med 1986;80(5):959–964.PubMedGoogle Scholar
  165. 165.
    Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 1983;286( 6361):266.Google Scholar
  166. 166.
    Foroozan R, Danesh-Meyer H, Savino PJ, Gamble G, Mekari-Sabbagh ON, Sergott RC. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology 2002;109(7):1267–1271.PubMedGoogle Scholar
  167. 167.
    Gonzalez-Alegre P, Ruiz-Lopez AD, AbarcaCostalago M, Gonzalez-Santos P. Increment of the platelet count in temporal arteritis: response to therapy and ischemic complications. Eur Neurol 2001;45(1):43–45.PubMedGoogle Scholar
  168. 168.
    Costello F, Zimmerman MB, Podhajsky PA, Hayreh SS. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol 2004;14(3):245–257.PubMedGoogle Scholar
  169. 169.
    Salvarani C, Cantini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu’ s arteritis. Clin Exp Rheumatol 2003;21(6 suppl 32):S23–28.PubMedGoogle Scholar
  170. 170.
    Guevara RA, Newman NJ, Grossniklaus HE. Positive temporal artery biopsy 6 months after prednisone treatment. Arch Ophthalmol 1998;116(9):1252–1253.PubMedGoogle Scholar
  171. 171.
    Liu GT, Volpe NJ, Galetta SL. Neuroophthalmology: diagnosis and management. Philadelphia: Saunders;2001.Google Scholar
  172. 172.
    Hall JK, Volpe NJ, Galetta SL, Liu GT, Syed NA, Balcer LJ. The role of unilateral temporal artery biopsy. Ophthalmology 2003;110(3):543–548.PubMedGoogle Scholar
  173. 173.
    Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976;51(8):504–510.PubMedGoogle Scholar
  174. 174.
    Danesh-Meyer HV, Savino PJ, Eagle RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuro-Ophthalmol 2000;20:213–215.Google Scholar
  175. 175.
    Pless M, Rizzo JF III, Lamkin JC, Lessell S. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuro-Ophthalmol 2000;20(3):216–218.Google Scholar
  176. 176.
    Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol 2002;86(5):530–532.PubMedGoogle Scholar
  177. 177.
    Lie JT. Temporal artery biopsy diagnosis of giant cell arteritis: lessons from 1109 biopsies. Anat Pathol 1996;1:69–97.PubMedGoogle Scholar
  178. 178.
    Poller DN, van Wyk Q, Jeffrey MJ. The importance of skip lesions in temporal arteritis. J Clin Pathol 2000;53(2):137–139.PubMedGoogle Scholar
  179. 179.
    McDonnell PJ, Moore G W, Miller NR, Hutchins GM, Green WR. Temporal arteritis. A clinicopathologic study. Ophthalmology 1986;93(4):518–530.PubMedGoogle Scholar
  180. 180.
    Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol 1997;42(2):99–123.PubMedGoogle Scholar
  181. 181.
    Nordborg E, Nordborg C. Giant cell arteritis: strategies in diagnosis and treatment. Curr Opin Rheumatol 2004;16(1):25–30.PubMedGoogle Scholar
  182. 182.
    Ho AC, Sergott RC, Regillo CD, et al. Color Doppler hemodynamics of giant cell arteritis. Arch Ophthalmol 1994;112(7):938–945.PubMedGoogle Scholar
  183. 183.
    Schmid R, Hermann M, Yannar A, Baumgartner RW. Color duplex ultrasound of the temporal artery: replacement for biopsy in temporal arteritis. Ophthalmologica 2002;216(1):16–21.PubMedGoogle Scholar
  184. 184.
    Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997;337(19):1336–1342.PubMedGoogle Scholar
  185. 185.
    Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002;137(4):232–238.PubMedGoogle Scholar
  186. 186.
    Morgenstern KE, Ellis BD, Schochet SS, Linberg JV. Bilateral optic nerve sheath enhancement from giant cell arteritis. J Rheumatol 2003;30(3):625–627.PubMedGoogle Scholar
  187. 187.
    Lee AG, Eggenberger ER, Kaufman DI, Manrique C. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuro-Ophthalmol 1999;19(4):235–237.Google Scholar
  188. 188.
    Harada S, Mitsunobu F, Kodama F, et al. Giant cell arteritis associated with rheumatoid arthritis monitored by magnetic resonance angiography. Intern Med 1999;38(8):675–678.PubMedGoogle Scholar
  189. 189.
    Mitomo T, Funyu T, Takahashi Y, Murakami K, Koyama K, Kamio K. Giant cell arteritis and magnetic resonance angiography. Arthritis Rheum 1998;41(9):1702.PubMedGoogle Scholar
  190. 190.
    Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000;18(4 suppl 20):S43–48.PubMedGoogle Scholar
  191. 191.
    Zborowska B, Ell J, McGhee-Collett M, Scolyer R, McCluskey PJ. Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis. Clin Exp Ophthalmol 2004;32(3):335–336.Google Scholar
  192. 192.
    Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003;110(6):1204–1215.PubMedGoogle Scholar
  193. 193.
    Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 2003;217(4):239–259.PubMedGoogle Scholar
  194. 194.
    Foroozan R, Deramo VA, Buono LM, et al. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology 2003;110(3):539–542.PubMedGoogle Scholar
  195. 195.
    Kim N, Trobe JD, Flint A, Keoleian G. Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. J Neuro-Ophthalmol 2003;23(2):122–126.Google Scholar
  196. 196.
    Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin N Am 1997;81(1):195–219.PubMedGoogle Scholar
  197. 197.
    Andersson R, Malmvall BE, Bengtsson BA. Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand 1986;220(5):465–469.PubMedGoogle Scholar
  198. 198.
    Bengtsson B A, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 1981;209(5):337–345.PubMedGoogle Scholar
  199. 199.
    Chan CC, Paine M, O’Day J. Predictors of recurrent ischemic optic neuropathy in giant cell arteritis. J Neuro-Ophthalmol 2005;25(1):14–17.Google Scholar
  200. 200.
    Doury P, Pattin S, Eulry F, Thabaut A. The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 1983;26(5):689–690.PubMedGoogle Scholar
  201. 201.
    Krall PL, Mazanec DJ, Wilke WS. Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. Cleve Clin J Med 1989;56(3):253–257.PubMedGoogle Scholar
  202. 202.
    Spiera RF, Kupersmith M, Paget S, Spiera H. Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al. Arthritis Rheum 2003;48(4):1159–1160.PubMedGoogle Scholar
  203. 203.
    Utsinger PD. Treatment of steroid nonresponsive giant cell arteritis with Cytoxan. Arthritis Rheum 1982;25(suppl):S31.Google Scholar
  204. 204.
    Hoffman GS, Cid MC, Hellmann DB, et al.; International Network for the Study of Systemic Vasculitides. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46(5):1309–1318.PubMedGoogle Scholar
  205. 205.
    Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;134(2):106–114.PubMedGoogle Scholar
  206. 206.
    Spiera RF, Mitnick HJ, Kupersmith M, et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001;19(5):495–501.PubMedGoogle Scholar
  207. 207.
    De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986;45(2):136–138.PubMedGoogle Scholar
  208. 208.
    Schaufelberger C, Andersson R, Nordborg E. No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study. Br J Rheumatol 1998;37(4):464–465.PubMedGoogle Scholar
  209. 209.
    Cantini F, Niccoli L, Salvarani C, Padula A, Olivieri I. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001;44(12):2933–2935.PubMedGoogle Scholar
  210. 210.
    Airo P, Antonioli CM, Vianelli M, Toniati P. Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs. Rheumatology (Oxf) 2002;41(3):347–349.Google Scholar
  211. 211.
    Andonopoulos AP, Meimaris N, Daoussis D, Bounas A, Giannopoulos G. Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis. Ann Rheum Dis 2003;62(11):1116.PubMedGoogle Scholar
  212. 212.
    Uthman I, Kanj N, Atweh S. Infliximab as monotherapy in giant cell arteritis. Clin Rheumatol 2006;25(1):109–110.PubMedGoogle Scholar
  213. 213.
    Tan AL, Holdsworth J, Pease C, Emery P, McGonagle D. Successful treatment of resistant giant cell arteritis with etanercept. Ann Rheum Dis 2003;62(4):373–374.PubMedGoogle Scholar
  214. 214.
    Weyand CM, Kaiser M, Yang H, Younge B, Goronzy JJ. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002;46(2):457–466.PubMedGoogle Scholar
  215. 215.
    Ruegg S, Engelter S, Jeanneret C, et al. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltim) 2003;82(1):1–12.Google Scholar
  216. 216.
    Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50(4):1332–1337.PubMedGoogle Scholar
  217. 217.
    Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 2002;80(4):355–367.PubMedGoogle Scholar
  218. 218.
    Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997;36(2):251–254.PubMedGoogle Scholar
  219. 219.
    Schmidt D, Vaith P, Hetzel A. Prevention of serious ophthalmic and cerebral complications in temporal arteritis? Clin Exp Rheumatol 2000;18(4 suppl 20):S61–63.PubMedGoogle Scholar
  220. 220.
    Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998;41(8):1497–1504.PubMedGoogle Scholar
  221. 221.
    Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1993;100(4):550–555.PubMedGoogle Scholar
  222. 222.
    Hsu CT, Kerrison JB, Miller NR, Goldberg MF. Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina 2001;21(4):348–351.PubMedGoogle Scholar
  223. 223.
    Duran E, Merkel PA, Sweet S, Swan N, Babikian VL. ANCA-associated small vessel vasculitis presenting with ischemic optic neuropathy. Neurology 2004;62(1):152–153.PubMedGoogle Scholar
  224. 224.
    Khurma V, Appen R, Wolf MD, Hansen KE. Wegener granulomatosis presenting as bilateral loss of vision. Clin Rheumatol 2005;11(5):267–269.Google Scholar
  225. 225.
    Hayakawa K, Akatsuka I, Matsukura S, Kawai K, Ohkuma H, Shimamura K. Case of anterior ischemic optic neuropathy accompanied by Churg-Strauss syndrome. Nippon Ganka Gakkai Zasshi 2004;108(10):612–617.PubMedGoogle Scholar
  226. 226.
    Khairallah M, Zaouali S, Ben Yahia S, et al. Anterior ischemic optic neuropathy associated with Rickettsia conorii infection. J Neuro-Ophthalmol 2005;25(3):212–214.Google Scholar
  227. 227.
    Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 2001;132(5):743–750.PubMedGoogle Scholar
  228. 228.
    Buono LM, Foroozan R. Perioperative posterior ischemic optic neuropathy: review of the literature. Surv Ophthalmol 2005;50(1):15–26.PubMedGoogle Scholar
  229. 229.
    Saul GV, Sarkies NJC. PION due to internal carotid artery occlusion. Neuro-Ophthalmology 1987;7:349–353.Google Scholar
  230. 230.
    Tsai RK, Sun CY. Spontaneous dissection of internal carotid artery presenting as isolated posterior ischaemic optic neuropathy. Br J Ophthalmol 1997;81(6):513.PubMedGoogle Scholar
  231. 231.
    Hashimoto M, Ohtsuka K, Suzuki Y, Hoyt WF. A case of posterior ischemic optic neuropathy in a posterior-draining dural cavernous sinus fistula. J Neuro-Ophthalmol 2005;25(3):176–179.Google Scholar
  232. 232.
    Kothe AC, Flanagan J, Trevino RC. True posterior ischemic optic neuropathy associated with herpes zoster ophthalmicus. Optom Vis Sci 1990;67(11):845–849.PubMedGoogle Scholar
  233. 233.
    Weinstein JM, Morris GL, Zurhein GM, Gentry LR. Posterior ischemic optic neuropathy due to Aspergillus fumigatus. J Clin Neuro-Ophthalmol 1989;9(1):7–13.Google Scholar
  234. 234.
    Lee AG, Brazis PW, Miller NR. Posterior ischemic optic neuropathy associated with migraine. Headache 1996;36(8):506–510.PubMedGoogle Scholar
  235. 235.
    Claes C, Milea D, Bodaghi B, Tran TH, LeHoang P, Blanc R. Acute retrobulbar optic neuropathy due to rupture of an anterior communicating artery aneurysm. Acta Ophthalmol Scand 2006;84(1):145–146.PubMedGoogle Scholar
  236. 236.
    Hara N, Mukuno K, Ohtaka H, Shimizu K. Ischemic optic neuropathy associated with subarachnoid hemorrhage after rupture. Ophthalmologica 2003;217(1):79–84.PubMedGoogle Scholar
  237. 237.
    Perlman JI, Forman S, Gonzalez ER. Retrobulbar ischemic optic neuropathy associated with sickle cell disease. J Neuro-Ophthalmol 1994;14(1):45–48.Google Scholar
  238. 238.
    Balm AJ, Brown DH, De Vries WA, Snow GB. Blindness: a potential complication of bilateral neck dissection. J Laryngol Otol 1990;104(2):154–156.PubMedGoogle Scholar
  239. 239.
    Chang SH, Miller NR. The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery: the Johns Hopkins Hospital Experience. Spine 2005;30(11):1299–1302.PubMedGoogle Scholar
  240. 240.
    Maran AG, Amin M, Wilson JA. Radical neck dissection: a 19-year experience. J Laryngol Otol 1989;103(8):760–764.PubMedGoogle Scholar
  241. 241.
    Nuttall GA, Garrity JA, Dearani JA, Abel MD, Schroeder DR, Mullany CJ. Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: a matched case/control study. Anesth Analg 2001;93(6):1410–1416.PubMedGoogle Scholar
  242. 242.
    Stevens WR, Glazer PA, Kelley SD, Lietman TM, Bradford DS. Ophthalmic complications after spinal surgery. Spine 1997;22(12):1319–1324.PubMedGoogle Scholar
  243. 243.
    Sweeney PJ, Breuer AC, Selhorst JB, et al. Ischemic optic neuropathy: a complication of cardiopulmonary bypass surgery. Neurology 1982;32(5):560–562.PubMedGoogle Scholar
  244. 244.
    Cheng MA, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey. Neurosurgery 2000;46(3):625–630.PubMedGoogle Scholar
  245. 245.
    Purvin V, Kuzma B. Intraorbital optic nerve signal hyperintensity on magnetic resonance imaging sequences in perioperative hypotensive ischemic optic neuropathy. J Neuro-Ophthalmol 2005;25(3):202–204.Google Scholar
  246. 246.
    Vaphiades MS. Optic nerve enhancement in hypotensive ischemic optic neuropathy. J Neuro-Ophthalmol 2004;24(3):235–236.Google Scholar
  247. 247.
    Johnson MW, Kincaid MC, Trobe JD. Bilateral retrobulbar optic nerve infarctions after blood loss and hypotension. A clinicopathologic case study. Ophthalmology 1987;94(12):1577–1584.PubMedGoogle Scholar
  248. 248.
    Nawa Y, Jaques JD, Miller NR, Palermo RA, Green WR. Bilateral posterior optic neuropathy after bilateral radical neck dissection and hypotension. Graefes Arch Clin Exp Ophthalmol 1992;230(4):301–308.PubMedGoogle Scholar
  249. 249.
    Schobel GA, Schmidbauer M, Millesi W, Undt G. Posterior ischemic optic neuropathy following bilateral radical neck dissection. Int J Oral Maxillofac Surg 1995;24(4):283–287.PubMedGoogle Scholar
  250. 250.
    Dzau VJ. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001;37:1047–1052.PubMedGoogle Scholar
  251. 251.
    McAuley DF, McGurk C, Nugent AG, et al. Vasoconstriction to endothelin-1 is blunted in non-insulin-dependent diabetes: a doseresponse study. Clin Sci (Lond) 2000;99:175–179.Google Scholar
  252. 252.
    Hayreh SS. Ischaemic optic neuropathy. Indian J Ophthalmol 2000 48(3):171–194.PubMedGoogle Scholar
  253. 253.
    Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84(3):732–747.Google Scholar
  254. 254.
    Kirkali P, Kansu T. A case of unilateral posterior ischemic optic neuropathy after radical neck dissection. Ann Ophthalmol 1990;22(8):297–298.PubMedGoogle Scholar
  255. 255.
    Marks SC, Jaques DA, Hirata RM, Saunders JR Jr. Blindness following bilateral radical neck dissection. Head Neck 1990;12(4):342–345.PubMedGoogle Scholar
  256. 256.
    Milner GA. A case of blindness after bilateral neck dissection. J Laryngol Otol 1960;74:880–885.PubMedGoogle Scholar
  257. 257.
    Pazos GA, Leonard DW, Blice J, Thompson DH. Blindness after bilateral neck dissection: case report and review. Am J Otolaryngol 1999;20(5):340–345.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Jane W. Chan
    • 1
  1. 1.Ophthalmology and NeurologyUniversity of Kentucky College of MedicineLexingtonUSA

Personalised recommendations